Human Genome Epidemiology Literature Finder
|
Records 1 - 11 (of 11 Records) |
| Query Trace: Polycythemia Vera and DNMT3A[original query] |
|---|
| Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms. Genes, chromosomes & cancer 2012 Aug 51 (8): 743-55. Brecqueville Mandy, Rey Jérôme, Bertucci François, Coppin Emilie, Finetti Pascal, Carbuccia Nadine, Cervera Nathalie, Gelsi-Boyer Véronique, Arnoulet Christine, Gisserot Olivier, Verrot Denis, Slama Borhane, Vey Norbert, Mozziconacci Marie-Joelle, Birnbaum Daniel, Murati An |
| Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon a-2a. Blood 2013 Aug 122 (6): 893-901. Quintás-Cardama Alfonso, Abdel-Wahab Omar, Manshouri Taghi, Kilpivaara Outi, Cortes Jorge, Roupie Anne-Laure, Zhang Su-Jiang, Harris David, Estrov Zeev, Kantarjian Hagop, Levine Ross L, Verstovsek Srd |
| Bone marrow findings in blast phase of polycythemia vera. Annals of hematology 2017 12 97 (3): 425-434. Hidalgo López Juliana E, Carballo-Zarate Adrian, Verstovsek Srdan, Wang Sa A, Hu Shimin, Li Shaoying, Xu Jie, Zuo Wenli, Tang Zhenya, Yin C Cameron, Medeiros L Jeffrey, Bueso-Ramos Carlos E, Tang Guil |
| [The genetic characteristics of BCR-ABL-negative myeloproliferative neoplasms]. Zhonghua nei ke za zhi 2019 12 59 (1): 35-39. Lyu X D, Li Y W, Guo Z, Xin Y P, Hu J Y, Fan R H, Song Y |
| Mutational profiling in myelofibrosis: implications for management. International journal of hematology 2019 10 111 (2): 192-199. Bose Prithviraj, Verstovsek Srd |
| Combination of myeloproliferative neoplasm driver gene activation with mutations of splice factor or epigenetic modifier genes increases risk of rapid blastic progression. European journal of haematology 2021 1 106 (4): 520-528. Bartels Stephan, Vogtmann Julia, Schipper Elisa, Büsche Guntram, Schlue Jerome, Lehmann Ulrich, Kreipe Ha |
| TET2, DNMT3A, IDH1, and JAK2 Mutation in Myeloproliferative Neoplasms in southern Iran. International journal of organ transplantation medicine 2022 5 12 (3): 12-20. Abedi E, Ramzi M, Karimi M, Yaghobi R, Mohammadi H, Bayat E, Moghadam M, Farokhian F, Dehghani M, Golafshan H A, Haghpanah |
| [Relationship between DTA Mutations and Thromboembolism in Patients with Myeloproliferative Neoplasms]. Zhongguo shi yan xue ye xue za zhi 2024 6 32 (3): 819-824. Min Wang, Hong-Yu Zhao, Da-Qi Li, Ping Ch |
| DNMT3A/TET2/ASXL1 mutations are an age-independent thrombotic risk factor in polycythemia vera patients: an observational study. Thrombosis and haemostasis 2024 1 . Adrián Segura-Díaz, Ruth Stuckey, Yanira Florido, Marta Sobas, Alberto Alvarez-Larran, Francisca Ferrer, Manuel M Pérez-Encinas, Gonzalo Carreño-Tarragona, María Laura Fox, Barbara Tazón Vega, Barbara Cuevas, Juan Francisco López Rodríguez, Nuria Farías-Sánchez, Jesús M González-Martín, María Teresa Gómez-Casares, Cristina Bilbao-Siey |
| Genomic classification and outcomes of young patients with polycythemia vera and essential thrombocythemia according to the presence of splanchnic vein thrombosis and its chronology. Annals of hematology 2024 1 . Marta Garrote, Mónica López-Guerra, Juan Carlos García-Pagán, Eduardo Arellano-Rodrigo, Francisca Ferrer-Marín, Juan Carlos Hernández-Boluda, Beatriz Bellosillo, Meritxell Nomdedeu, Virginia Hernández-Gea, Ana Triguero, Francesca Guijarro, José Álamo, Anna Baiges, Fanny Turon, Dolors Colomer, Francisco Cervantes, Alberto Alvarez-Larr |
| Idiopathic erythrocytosis: a germline disease? Clinical and experimental medicine 2024 1 24 (1): 11. E M Elli, M Mauri, D D'Aliberti, I Crespiatico, D Fontana, S Redaelli, S Pelucchi, S Spinelli, B Manghisi, F Cavalca, A Aroldi, A Ripamonti, S Ferrari, S Palamini, F Mottadelli, L Massimino, D Ramazzotti, G Cazzaniga, A Piperno, C Gambacorti-Passerini, R Piaz |
- Page last reviewed:Feb 1, 2024
- Content source: